There are no clear-cut clinical distinctions between DDD and C3GN, although patients with DDD are more likely to have low levels of C3 in circulation6 and to have a C3 nephritic factor10, an autoantibody that stabilises the alternative pathway C3 convertase. This evidence concerns the gene C3 and Dowling-Degos disease 1.